Published in J Gynecol Oncol on June 30, 2010
Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood (2005) 2.81
Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy. J Immunother (2010) 1.89
Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer. J Thorac Oncol (2010) 1.73
A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer. Oncol Rep (2009) 1.20
Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science (2002) 4.72
The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma. Gynecol Oncol (2011) 2.76
Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes. Gynecol Oncol (2008) 1.89
Laparoscopic management of early uterine cancer: 10-year experience in Asan Medical Center. Gynecol Oncol (2007) 1.81
Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin. Gynecol Oncol (2012) 1.49
VDUP1 is required for the development of natural killer cells. Immunity (2005) 1.31
Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer. Gynecol Oncol (2007) 1.23
Carbon monoxide mediates heme oxygenase 1 induction via Nrf2 activation in hepatoma cells. Biochem Biophys Res Commun (2006) 1.13
Adipose-derived stem cells as a new therapeutic modality for ageing skin. Exp Dermatol (2011) 1.09
Malignant transformation of mature cystic teratoma of the ovary: experience at a single institution. Eur J Obstet Gynecol Reprod Biol (2008) 1.09
Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery. Gynecol Oncol (2009) 1.06
Papillary mucinous metaplasia of the endometrium as a possible precursor of endometrial mucinous adenocarcinoma. Mod Pathol (2012) 1.06
Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer. J Gynecol Oncol (2008) 1.06
Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007. J Cancer Res Clin Oncol (2008) 1.05
Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol (2008) 1.04
The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low-grade endometrial stromal sarcoma of the uterus. Ann Surg Oncol (2011) 1.03
Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition. J Gynecol Oncol (2013) 1.02
Epidemiological characteristics of ovarian cancer in Korea. J Gynecol Oncol (2010) 0.98
Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors? Gynecol Oncol (2006) 0.98
Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial. J Transl Med (2011) 0.97
Further stratification of risk groups in patients with lymph node metastasis after radical hysterectomy for early-stage cervical cancer. Gynecol Oncol (2010) 0.97
Neoadjuvant chemotherapy with paclitaxel plus platinum followed by radical surgery in early cervical cancer during pregnancy: three case reports. Jpn J Clin Oncol (2010) 0.95
Laparoscopic versus open radical hysterectomy in patients with stage IB2 and IIA2 cervical cancer. J Surg Oncol (2013) 0.94
Peroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cells. Cancer Invest (2011) 0.94
Vaginal cuff dehiscence after hysterectomy. Int J Gynaecol Obstet (2013) 0.94
Comparison of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer. Ann Surg Oncol (2008) 0.94
Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary. Gynecol Oncol (2011) 0.93
Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer. J Gynecol Oncol (2012) 0.93
High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys (2009) 0.92
Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer quality of life questionnaire cervical cancer module. Oncology (2009) 0.92
Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study. Int J Gynecol Cancer (2010) 0.91
Laparoscopic versus open radical hysterectomy for elderly patients with early-stage cervical cancer. Am J Obstet Gynecol (2012) 0.90
Efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay in patients with epithelial ovarian cancer. J Gynecol Oncol (2009) 0.89
The efficacy of conservative management after conization in patients with stage IA1 microinvasive cervical carcinoma. Acta Obstet Gynecol Scand (2009) 0.89
Long-term outcomes after fertility-sparing laparoscopic radical trachelectomy in young women with early-stage cervical cancer: an Asan Gynecologic Cancer Group (AGCG) study. J Surg Oncol (2014) 0.88
Role of PET or PET/CT in the post-therapy surveillance of uterine sarcoma. Gynecol Oncol (2008) 0.86
Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002). Eur J Cancer (2012) 0.86
Prevalence and predictors of anxiety and depression among cervical cancer survivors in Korea. Int J Gynecol Cancer (2010) 0.86
The role of pelvic and/or para-aortic lymphadenectomy in surgical management of apparently early carcinosarcoma of uterus. Ann Surg Oncol (2010) 0.85
Radiation therapy is a treatment to be considered for recurrent epithelial ovarian cancer after chemotherapy. Tumori (2011) 0.85
Progression-free survival is accurately predicted in patients treated with chemotherapy for epithelial ovarian cancer by the histoculture drug response assay in a prospective correlative clinical trial at a single institution. Anticancer Res (2013) 0.85
Proliferation of CD4CD25Foxp3 regulatory T lymphocytes in ex vivo expanded ascitic fluid from primary and recurrent ovarian carcinoma. J Gynecol Oncol (2010) 0.85
Is chemotherapy-induced neutropenia a prognostic factor in patients with ovarian cancer? Acta Obstet Gynecol Scand (2010) 0.84
Micropapillary pattern in serous borderline ovarian tumors: does it matter? Gynecol Oncol (2011) 0.84
Postoperative nomogram predicting risk of recurrence after radical hysterectomy for early-stage cervical cancer. Int J Gynecol Cancer (2010) 0.84
Laparoscopic compared with open radical hysterectomy in obese women with early-stage cervical cancer. Obstet Gynecol (2012) 0.83
Human papillomavirus test after conization in predicting residual disease in subsequent hysterectomy specimens. Obstet Gynecol (2009) 0.83
Identification of differentially expressed microRNAs in endometrial cancer cells after progesterone treatment. Int J Gynecol Cancer (2012) 0.83
Secondary cytoreductive surgery in the management of platinum-sensitive recurrent epithelial ovarian cancer. J Surg Oncol (2010) 0.83
Hepatic resection as part of secondary cytoreductive surgery for recurrent ovarian cancer involving the liver. Arch Gynecol Obstet (2010) 0.82
Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy. Gynecol Oncol (2012) 0.82
In vitro chemosensitivity using the histoculture drug response assay in human epithelial ovarian cancer. Acta Med Okayama (2012) 0.82
Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage IB2-IIA bulky cervical cancer. J Gynecol Oncol (2009) 0.82
Hormonal therapy for women with stage IA endometrial cancer of all grades. Obstet Gynecol (2013) 0.81
Concurrent chemoradiotherapy or radiotherapy alone for locally advanced cervical cancer in elderly women. Tumori (2011) 0.81
Cloning and characterization of the 5'-flanking region of the Ehox gene. Biochem Biophys Res Commun (2006) 0.80
Korean epithelial ovarian cancer study (Ko-EVE): protocols and interim report. Asian Pac J Cancer Prev (2012) 0.80
Effect of mesenchymal stem cell transplantation on the engraftment of human hematopoietic stem cells and leukemic cells in mice model. Int J Hematol (2008) 0.79
Prognostic significance of stromal microinvasion in the intestinal type of ovarian mucinous adenocarcinoma. Ann Surg Oncol (2011) 0.79
Feasibility and outcome of concurrent chemoradiotherapy for recurrent cervical carcinoma after initial surgery. Tumori (2010) 0.79
Laparoscopic management of early-stage malignant nonepithelial ovarian tumors: surgical and survival outcomes. Int J Gynecol Cancer (2013) 0.79
Preoperative fluorine 18 fluorodeoxyglucose tumoral uptake ratio between upper and lower abdomen in primary advanced-stage ovarian cancer. Int J Gynecol Cancer (2013) 0.78
Mutational analysis of KRAS, BRAF, and TP53 genes of ovarian serous carcinomas in Korean women. Yonsei Med J (2009) 0.78
Optimal debulking surgery followed by paclitaxel/platinum chemotherapy is very effective in treating ovarian carcinosarcomas: a single center experience. Gynecol Obstet Invest (2011) 0.78
The role of loop electrosurgical excisional procedure in the management of adenocarcinoma in situ of the uterine cervix. Eur J Obstet Gynecol Reprod Biol (2009) 0.78
Poor prognosis of uterine serous carcinoma compared with grade 3 endometrioid carcinoma in early stage patients. Virchows Arch (2013) 0.78
Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors. Int J Gynecol Cancer (2016) 0.78
Chemosensitivity of uterine cervical cancer demonstrated by the histoculture drug response assay. Tohoku J Exp Med (2009) 0.77
Reliability of magnetic resonance imaging in assessing myometrial invasion absence in endometrial carcinoma. Acta Obstet Gynecol Scand (2009) 0.76
Transcriptional auto-regulation of the dopamine receptor regulating factor (DRRF) gene. Mol Cell Endocrinol (2008) 0.76
A comparative study of outside-in and inside-out transobturator tape procedures for stress urinary incontinence. Gynecol Obstet Invest (2010) 0.76
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement. J Gynecol Oncol (2016) 0.76
Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy. J Gynecol Oncol (2016) 0.75
Cytological Evaluation and REBA HPV-ID HPV Testing of Newly Developed Liquid-Based Cytology, EASYPREP: Comparison with SurePath. Korean J Pathol (2013) 0.75
Cost-utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model. Clinicoecon Outcomes Res (2013) 0.75
Erratum: Author correction. Obstet Gynecol Sci (2017) 0.75
A Long-term follow-up study of 91 cases with ovarian granulosa cell tumors. Anticancer Res (2014) 0.75
Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma. Int J Gynecol Cancer (2017) 0.75
Simultaneous suppression of Src and signal transducer and activator of transcription 3 inhibits the growth of epithelial ovarian cancer cells. Eur J Obstet Gynecol Reprod Biol (2013) 0.75
Paget's disease of the vulva: evaluation of recurrence relative to symptom duration, volumetric excision of lesion, and surgical margin status. Acta Obstet Gynecol Scand (2010) 0.75
Identification of a preoperative predictive factor for lymph node metastasis in uterine papillary serous carcinoma: long-term results from a single institution. Int J Gynecol Cancer (2015) 0.75
Preoperative Predictive Factors for Complete Cytoreduction and Survival Outcome in Epithelial Ovarian, Tubal, and Peritoneal Cancer After Neoadjuvant Chemotherapy. Int J Gynecol Cancer (2017) 0.75
Genomic organization and promoter characterization of the murine dopamine receptor regulating factor (DRRF) gene. Gene (2003) 0.75
Stratification of risk groups according to survival after recurrence in endometrial cancer patients. Medicine (Baltimore) (2017) 0.75